CRP and endothelial dysfunction: Plenty of evidence indicates that some increased proinflammatory molecules, such as high-sensitive C-reactive protein (hs-CRP), TNF-α, and IL-6, will aggravate joint destruction and induce other CV risk factors, including changes in lipid levels, metabolic syndrome insulin resistance, and endothelial dysfunction [17–19].